Modified Colorimetric Assay for Susceptibility Testing of Azole Antifungal Drugs against Candida Species

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1790-1793

  Chen, Jian ^a   Wan, Zhe ^a   Li, Ruoyu ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE;

ARTICLE; CANDIDA; COLORIMETRY; DILUTION; FUNGAL STRAIN; FUNGUS ISOLATION; GLUCOSE UTILIZATION; NONHUMAN; PRIORITY JOURNAL; STANDARD; YEAST;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA; COLORIMETRY; CULTURE MEDIA; FLUCONAZOLE; GLUCOSE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

CANDIDA; FUNGI;

EID: 16544366642     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1790-1793.2004     Document Type: Article

References (10)

1. Anaissie, E. J., J. H. Rex, O. Uzun, and S. Vartivarian. 1998. Predictors of adverse outcome in cancer patients with candidemia. Am. J. Med. 118:238-245.
2. Beck-Sague, C., and W. R. Jarvis. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect. Dis. 167:1247-1251.
3. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
4. Li, R. K., C. M. Elie, G. E. Clayton, and M. A. Ciblak. 2000. Comparison of a new colorimetric assay with the National Committee for Clinical Laboratory Standards broth microdilution method (M27-A) for antifungal drug MIC determination. J. Clin. Microbiol. 38:2334-2338.
5. Luzzati, R., G. Amalfitano, L. Lazzarini, F. Soldani, S. Bellino, M. Solbiati, M. C. Danzi, S. Vento, G. Todeschini, C. Vivenza, and E. Concia. 2000. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur. J. Clin. Microbiol. Infect. Dis. 19:602-607.
6. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Nguyen, M. H., J. E. Peacock, A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
8. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Clin. Infect. Dis. 24:235-247.
9. Riesselman, M. H., K. C. Hazen, and J. E. Cutler. 2000. Determination of antifungal MICs by a rapid susceptibility assay. J. Clin. Microbiol. 38:333-340.
10. Uzun, O., S. Ascioglu, E. J. Anaissie, and J. H. Rex. 2001. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin. Infect. Dis. 32:1713-1717.